AVROBIO logo
AVROBIO AVRO

Quartalsbericht 2026-Q1
hinzugefügt 07.05.2026

report update icon

AVROBIO Langfristiger Schuldenstrom 2011-2026 | AVRO

Langfristiger Schuldenstrom Jährlich AVROBIO

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
889 K 2.3 M 1.35 M 999 K - - - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
2.3 M 889 K 1.38 M

Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler

Name Langfristiger Schuldenstrom Preis % 24h Marktkapitalisierung Land
FSD Pharma FSD Pharma
HUGE
103 K - 5743.5 % $ 69.7 M canadaCanada
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
102 K - 1.35 % $ 17.8 M chinaChina
AgeX Therapeutics AgeX Therapeutics
AGE
181 K - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
Coherus BioSciences Coherus BioSciences
CHRS
1.83 M $ 1.63 - $ 191 M usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
382 M - - $ 96.9 B britainBritain
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
4.21 M $ 7.83 - $ 214 M israelIsrael
Athira Pharma Athira Pharma
ATHA
465 K - - $ 269 M usaUSA
BiondVax Pharmaceuticals Ltd. BiondVax Pharmaceuticals Ltd.
BVXV
773 K - 0.74 % $ 768 M israelIsrael
Galera Therapeutics Galera Therapeutics
GRTX
133 K - -32.59 % $ 7.61 M usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
5.82 M $ 4.4 - $ 1.31 B canadaCanada
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
7.93 M $ 17.3 - $ 809 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
4.56 M $ 1.59 - $ 423 M britainBritain
BioNTech SE BioNTech SE
BNTX
45 M $ 91.99 - $ 22.2 B germanyGermany
Compugen Ltd. Compugen Ltd.
CGEN
768 K $ 3.03 - $ 283 M israelIsrael
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
56 K $ 3.49 - $ 5.75 M israelIsrael
Aeterna Zentaris Aeterna Zentaris
AEZS
215 K - 5.93 % $ 314 M canadaCanada
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
554 K - 1.93 % $ 17.4 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
193 K - -45.71 % $ 1.2 M canadaCanada
Aptinyx Aptinyx
APTX
337 K - -39.0 % $ 4.57 M usaUSA
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
3.08 M - -0.23 % $ 916 M usaUSA
AlloVir AlloVir
ALVR
316 K - 4.14 % $ 49.1 M usaUSA
Allakos Allakos
ALLK
3.25 M - - $ 28.6 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
294 K $ 21.57 - $ 2.74 B usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
317 K - 3.16 % $ 1.9 M usaUSA
Fennec Pharmaceuticals Fennec Pharmaceuticals
FENC
2 K $ 9.24 - $ 264 M usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
2.1 M $ 3.12 - $ 649 M usaUSA
Eton Pharmaceuticals Eton Pharmaceuticals
ETON
65 K $ 29.96 - $ 806 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
274 K - -11.43 % $ 502 K usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
4.64 M - - $ 10.1 M usaUSA
Exelixis Exelixis
EXEL
27.9 M $ 51.1 - $ 13.9 B usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
756 K - - $ 2.17 B usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
48 K - 10.36 % $ 9.8 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
429 K - - $ 8.42 M usaUSA
Aravive Aravive
ARAV
2.2 M - -13.39 % $ 1.45 M usaUSA